Answers are grounded in this paper and cite their sources.
Gender-affirming hormone treatment (GAHT) is a common therapy for transgender individuals to reduce gender dysphoria and improve quality of life. Clarifying the long-term effects of GAHT remains a priority in transgender health research.
No takes yet. Share an insight, caveat, or question.
Hashemi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: